Cerebral oxygen metabolism and neuronal integrity in patients with impaired vasoreactivity attributable to occlusive carotid artery disease

Stroke

Volumn 37, Issue 2, 2006, Pages 393-398

  Kuroda, Satoshi ^a   Shiga, Tohru ^a   Houkin, Kiyohiro ^b   Ishikawa, Tatsuya ^a   Katoh, Chietsugu ^a   Tamaki, Nagara ^a   Iwasaki, Yoshinobu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Acetazolamide; Cerebral ischemia; Flumazenil; Metabolism; Oxygen

Indexed keywords

FLUMAZENIL; IOFETAMINE I 123; OXYGEN 15; 4 IODOAMPHETAMINE; 4-IODOAMPHETAMINE; AMPHETAMINE DERIVATIVE; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; OXYGEN;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN OXYGEN CONSUMPTION; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; BRAIN CIRCULATION; CAROTID ARTERY; CAROTID ARTERY DISEASE; DIGITAL SUBTRACTION ANGIOGRAPHY; HEMODYNAMICS; METABOLISM; METHODOLOGY; MIDDLE AGED; NECROSIS; PATHOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN BINDING; REGRESSION ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TIME;

AGED; AMPHETAMINES; ANGIOGRAPHY, DIGITAL SUBTRACTION; ARTERIAL OCCLUSIVE DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CEREBROVASCULAR CIRCULATION; FEMALE; FLUMAZENIL; GABA MODULATORS; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NECROSIS; OXYGEN; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; REGRESSION ANALYSIS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33644859807     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000198878.66000.4e     Document Type: Article

References (26)

1. Baron JC, Bousser MG, Rey A, Guillard A, Comar D, Castaigne P. Reversal of focal "misery-perfusion syndrome" by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15o positron emission tomography. Stroke. 1981;12:454-459.
2. Powers WJ, Grubb RL Jr, Raichle ME. Physiological responses to focal cerebral ischemia in humans. Ann Neurol. 1984;16:546-552.
3. Grubb RL Jr, Derdeyn CP, Fritsch SM, Carpenter DA, Yundt KD, Videen TO, Spitznagel EL, Powers WJ. Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. J Am Med Assoc. 1998;280:1055-1060.
4. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Ueno M, Nishizawa S, Konishi J, Shio H. Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases. J Nucl Med. 1999;40:1992-1998.
5. Derdeyn CP, Videen TO, Grubb RL Jr, Powers WJ. Comparison of pet oxygen extraction fraction methods for the prediction of stroke risk. J Nucl Med. 2001;42:1195-1197.
6. Kuroda S, Houkin K, Kamiyama H, Mitsumori K, Iwasaki Y, Abe H. Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? Stroke. 2001;32:2110-2116.
7. Ogasawara K, Ogawa A, Yoshimoto T. Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke. 2002;33:1857-1862.
8. Nemoto EM, Yonas H. Revisiting the question, "is the acetazolamide test valid for quantitative assessment of maximal cerebral autoregulatory vasodilation?" Stroke. 2001;32:1234-1237.
9. 2 responsiveness measured by positron emission tomography. J Cereb Blood Flow Metab. 1988;8:227-235.
10. 2 reactivity measured by the intravenous 133 xenon injection technique. J Neurol Neurosurg Psychiatry. 1988;51:1045-1050.
11. 123I-IMP single photon emission computed tomography in patients with major cerebral artery occlusive disease: correlation with positron emission tomography parameters. J Cereb Blood Flow Metab. 1994;14:763-770.
12. 123I-iodoamphetamine single-photon emission computed tomography in patients with carotid occlusive diseases. Stroke. 2002;33:2217-2223.
13. Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M. Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. AJNR Am J Neuroradiol. 1995;16:563-570.
14. Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M. Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease. J Neurol Neurosurg Psychiatry. 2004;75:33-37.
15. Nemoto EM, Yonas H, Kuwabara H, Pindzola RR, Sashin D, Meltzer CC, Price JC, Chang Y, Johnson DW. Identification of hemodynamic compromise by cerebrovascular reserve and oxygen extraction fraction in occlusive vascular disease. J Cereb Blood Flow Metab. 2004;24:1081-1089.
16. Kuroda S, Shiga T, Ishikawa T, Houkin K, Narita T, Katoh C, Tamaki N, Iwasaki Y. Reduced blood flow and preserved vasoreactivity characterize oxygen hypometabolism due to incomplete infarction in occlusive carotid artery diseases. J Nucl Med. 2004;45:943-949.
17. Garcia JH, Lassen NA, Weiller C, Sperling B, Nakagawara J. Ischemic stroke and incomplete infarction. Stroke. 1996;27:761-765.
18. Kuroda S, Kamiyama H, Abe H, Houkin K, Isobe M, Mitsumori K. Acetazolamide test in detecting reduced cerebral perfusion reserve and predicting long-term prognosis in patients with internal carotid artery occlusion. Neurosurgery. 1993;32:912-918.
19. Kuroda S, Takigawa S, Kamiyama H, Abe H, Sakuragi M, Motomiya M, Nakagawa T, Mitsumori K, Tsuru M. [diagnosis of hemodynamic compromise in patients with chronic cerebral ischemia; the detection of impaired vasodilatory capacity with 133xe spect and acetazolamide (diamox) test]. No Shinkei Geka. 1990;18:167-173.
20. Millet P, Graf C, Buck A, Walder B, Ibanez V. Evaluation of the reference tissue models for pet and spect benzodiazepine binding parameters. NeuroImage. 2002;17:928-942.
21. Ardekani BA, Braun M, Hutton BF, Kanno I, Iida H. A fully automatic multimodality image registration algorithm. J Comput Assist Tomogr. 1995;19:615-623.
22. Derdeyn CP, Videen TO, Yundt KD, Fritsch SM, Carpenter DA, Grubb RL, Powers WJ. Variability of cerebral blood volume and oxygen extraction: Stages of cerebral hemodynamic impairment revisited. Brain. 2002;125:595-607.
23. 123I-iomazenil uptake in hemodynamically and metabolically impaired brain areas in patients with cerebrovascular disease. Nucl Med Commun. 1996;17:701-705.
24. 123I-iomazenil brain spect. Ann Nucl Med. 1999;13:261-264.
25. Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke. 1997;28:124-132.
26. Yamauchi H, Fukuyama H, Nagahama Y, Nabatame H, Nakamura K, Yamamoto Y, Yonekura Y, Konishi J, Kimura J. Evidence of misery perfusion and risk for recurrent stroke in major cerebral arterial occlusive diseases from pet. J Neurol Neurosurg Psychiatry. 1996;61:18-25.